Insulin-mediated signaling promotes proliferation and survival of glioblastoma through Akt activation

BACKGROUND: Metabolic complications such as obesity, hyperglycemia, and type 2 diabetes are associated with poor outcomes in patients with glioblastoma. To control peritumoral edema, use of chronic high-dose steroids in glioblastoma patients is common, which can result in de novo diabetic symptoms....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Gong, Yuanying, Ma, Yufang, Sinyuk, Maksim, Loganathan, Sudan, Thompson, Reid C., Sarkaria, Jann N., Chen, Wenbiao, Lathia, Justin D., Mobley, Bret C., Clark, Stephen W., Wang, Jialiang
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Basic and Translational Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4677408/
https://ncbi.nlm.nih.gov/pubmed/26136493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov096
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars